ERBB2 and breast cancer: Furthermore, DeepTEPP is to our knowledge the first known deep learning model to guide anti-HER2 (de-)escalation, providing an important reference for choosing the appropriate individualized treatment for HER2-positive breast cancer patients in a non-invasive way.